Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis.


Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
05 04 2019
Historique:
received: 02 03 2018
accepted: 25 03 2019
entrez: 7 4 2019
pubmed: 7 4 2019
medline: 10 5 2020
Statut: epublish

Résumé

Opioids are routinely used to treat a variety of chronic conditions associated with pain. However, they are a class of medications with a significant potential for adverse health effects, with and without misuse. Opioid misuse, as defined as inappropriate use of appropriately prescribed opioids, is becoming more well-recognized publicly but does not have clear treatment options. Opioid misuse has been linked to variety of poor outcomes and its consequences have a significant impact on healthcare resource utilization. The evidence on harm reduction strategies to mitigate adverse events prompting presentation to acute care settings for patients presenting with long-term opioid use is sparse. We will perform a systematic review and meta-analysis to catalog effective harm reduction strategies and identify the most effective ones to reduce avoidable healthcare utilization in patients on long-term opioid therapy who present to acute health care settings with complications attributed to opioid misuse. A search strategy will be developed and executed by an information specialist; electronic databases (MEDLINE, EMBASE, CINAHL, Cochrane Library) and additional sources will be searched. Search themes will include opioids, chronic drug use, and acute healthcare settings. Citation screening, selection, quality assessment, and data abstraction will be performed in duplicate. A comprehensive inventory of harm reduction strategies will be developed. Data will be collected on patient-related outcomes associated with each identified harm reduction strategy. When sufficiently homogeneous data on interventions, population, and outcomes is available, it will be pooled for aggregate analysis. Evaluation of the methodological quality of individual studies and of the quality of the body of evidence will be performed. Our primary objective will be to identify harm reduction strategies that have been shown to result in clinically relevant and statistically significant improvements in patient outcomes and/or decreased healthcare utilization. This study will better characterize harm reduction strategies for patients on long-term prescribed opioids presenting to acute healthcare settings. It will also add new knowledge and generate greater understanding of key knowledge gaps of the long-term prescribed opioid use and its impact on healthcare utilization. CRD42018088962 .

Identifiants

pubmed: 30953550
doi: 10.1186/s13643-019-0997-5
pii: 10.1186/s13643-019-0997-5
pmc: PMC6449896
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88

Références

Pain Res Manag. 2003 Winter;8(4):189-94
pubmed: 14679412
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Crit Care. 2017 Feb;37:261
pubmed: 27876483
Addiction. 2008 Sep;103(9):1500-8
pubmed: 18636996
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
J Intensive Care Med. 2017 Aug;32(7):429-435
pubmed: 26609023
J Hosp Med. 2014 Feb;9(2):73-81
pubmed: 24227700
Inj Prev. 2018 Feb;24(1):48-54
pubmed: 28835443
Popul Health Manag. 2014 Dec;17(6):372-87
pubmed: 25075734
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
BMJ. 2018 Aug 1;362:k2833
pubmed: 30068513
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
Can Fam Physician. 2014 Sep;60(9):826-32
pubmed: 25217680
J Trauma. 2007 Mar;62(3):755-8
pubmed: 17414360
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
J Opioid Manag. 2012 Mar-Apr;8(2):81-7
pubmed: 22616313
J Pain Symptom Manage. 1996 Apr;11(4):203-17
pubmed: 8869456
South Med J. 2017 Mar;110(3):217-222
pubmed: 28257549
Ann Intensive Care. 2017 Sep 2;7(1):88
pubmed: 28866754
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Ann Intern Med. 2010 Jan 19;152(2):85-92
pubmed: 20083827
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Pain Symptom Manage. 1996 May;11(5):274-86
pubmed: 8636626
Can J Pain. 2017 May 4;1(1):2-7
pubmed: 35005336
J Pain Symptom Manage. 1993 Jul;8(5):265-78
pubmed: 7525743
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S28-38
pubmed: 12479252
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Eur J Pain. 2007 Jul;11(5):490-518
pubmed: 17070082
Arch Intern Med. 2003 Sep 22;163(17):2014-8
pubmed: 14504113
Ann Am Thorac Soc. 2017 Dec;14(12):1803-1809
pubmed: 28800256
Int J Technol Assess Health Care. 2012 Apr;28(2):138-44
pubmed: 22559755
JAMA. 1999 Jul 21;282(3):267-70
pubmed: 10422996
J Stud Alcohol Drugs. 2011 Sep;72(5):774-86
pubmed: 21906505
J Trauma Acute Care Surg. 2014 Jan;76(1):172-5
pubmed: 24368374
Pain Ther. 2017 Dec;6(2):203-215
pubmed: 28887789

Auteurs

Jean Deschamps (J)

Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 2-124E, Clinical Sciences Building, 8440-112 St, Edmonton, NW, T6G 2B7, Canada. jean3@ualberta.ca.

James Gilbertson (J)

School of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Sebastian Straube (S)

Division of Preventative Medicine, Department of Medicine, University of Alberta, 5-30 University Terrace, 8303-112 St. NW, Edmonton, Alberta, T6G 2T4, Canada.

Kathryn Dong (K)

Department of Emergency Medicine, University of Alberta, 2J2.00 WC Mackenzie Health Sciences Centre, 8440 112 St. NW, Edmonton, Alberta, T6G 2R7, Canada.

Frank P MacMaster (FP)

Departments of Psychiatry and Pediatrics, University of Calgary, Strategic Clinical Network for Addictions and Mental Health, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada.

Christina Korownyk (C)

Department of Family Medicine, University of Alberta, Suite 205 College Plaza, 8215 112 St. NW, Edmonton, Alberta, T6G 2C8, Canada.

Lori Montgomery (L)

Department of Family Medicine, Calgary Chronic Pain Center, 1820 Richmond Road SW, Calgary, Alberta, T2T 5C7, Canada.

Ryan Mahaffey (R)

Department of Anesthesia, University of Ottawa, Ottawa, Ontario, Canada.

James Downar (J)

Department of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.

Hance Clarke (H)

Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Transitional Pain Program, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

John Muscedere (J)

Department of Critical Care Medicine, Queen's University, Kingston, Ontario, Canada.

Katherine Rittenbach (K)

Addiction and Mental Health Strategic Clinical Network, Alberta Health Services, Edmonton, Alberta, Canada.
Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.

Robin Featherstone (R)

Alberta Research Centre for Health Evidence, Department of Pediatrics, University of Alberta, Alberta,, Canada.
Alberta SPOR SUPPORT Unit KT Platform, Edmonton Clinical Health Academy, 4-486D, 11405-87 Avenue, Edmonton, Alberta, T6G 1C9, Canada.

Meghan Sebastianski (M)

Knowledge Translation Platform, Alberta SPOR SUPPORT Unit Department of Pediatrics, University of Alberta, 362-B Heritage Medical Research Centre (HMRC), Alberta, Canada.

Ben Vandermeer (B)

Alberta Research Centre for Health Evidence, Department of Pediatrics, University of Alberta, Alberta,, Canada.
Alberta SPOR SUPPORT Unit KT Platform, Edmonton Clinical Health Academy, 4-486D, 11405-87 Avenue, Edmonton, Alberta, T6G 1C9, Canada.

Deborah Lynam (D)

Primary Health Care Information Network, Edmonton, Alberta, Canada.

Ryan Magnussen (R)

Critical Care Strategic Clinical Network, Foothills Medical Centre, ICU Administration-Ground Floor, McCaig Tower, 3134 Hospital Drive, Calgary, Alberta, T2N 2T9, Canada.

Sean M Bagshaw (SM)

Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 2-124E, Clinical Sciences Building, 8440-112 St, Edmonton, NW, T6G 2B7, Canada.

Oleksa G Rewa (OG)

Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 2-124E, Clinical Sciences Building, 8440-112 St, Edmonton, NW, T6G 2B7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH